Perpetual legal action continues
The future of investment house, Elderslie Finance Corporation, remains in the balance following proceedings in the Federal Court last week suggesting the business is about to be sold and, as a result, will receive a cash injection.
The Federal Court on Friday adjourned its decision on an application by Perpetual Limited subsidiary, Perpetual Trustees WA Limited, for various orders against Elderslie after the company provided new evidence including a contract of sale and provided a number of undertakings to the court that served to preserve the financial position of the company during the term of the adjournment.
Perpetual had sought the orders in late May after a report conducted by PricewaterhouseCoopers suggested it was likely Elderslie was or would become insolvent unless the company was sold and received a significant cash injection to meet its short-term liquidity requirements.
Perpetual general manager trust and fund services Chris Green said the sale of the company together with a significant injection of capital would be in the best interests of debenture holders.
“Given the new material provided in court evidencing a signed contract of sale and further affidavit evidence supporting an injection of funds into the company, Perpetual Trustees WA did not contest the adjournment until 1 July, 2008,” he said.
AUTHOR
Mike Taylor
Recommended for you
Compared to four years ago when the divide between boutique and large licensees were largely equal, adviser movements have seen this trend shift in light of new licensees commencing.
As ongoing market uncertainty sees advisers look beyond traditional equity exposure, Fidante has found adviser interest in small caps and emerging markets for portfolio returns has almost doubled since April.
CoreData has shared the top areas of demand for cryptocurrency advice but finds investors are seeking advisers who actively invest in the asset themselves.
With regulators ‘raising the bar’ on retirement planning, Lonsec Research and Ratings has urged advisers to place greater focus on sequencing and longevity risk as they navigate clients through the shifting landscape.
